These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20232138

  • 1. Association of TGFB1 -509 C>T polymorphism with breast cancer: evidence from a meta-analysis involving 23,579 subjects.
    Niu W, Qi Y, Gao P, Zhu D.
    Breast Cancer Res Treat; 2010 Nov; 124(1):243-9. PubMed ID: 20232138
    [Abstract] [Full Text] [Related]

  • 2. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
    Qiu LX, Yao L, Mao C, Chen B, Zhan P, Xue K, Zhang J, Yuan H, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):563-7. PubMed ID: 20143152
    [Abstract] [Full Text] [Related]

  • 3. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
    Gu D, Zhuang L, Huang H, Cao P, Wang D, Tang J, Chen J.
    Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
    [Abstract] [Full Text] [Related]

  • 4. Association of a TGF-β1 gene -509 C/T polymorphism with breast cancer risk: a meta-analysis.
    Woo SU, Park KH, Woo OH, Yang DS, Kim AR, Lee ES, Lee JB, Kim YH, Kim JS, Seo JH.
    Breast Cancer Res Treat; 2010 Nov; 124(2):481-5. PubMed ID: 20361250
    [Abstract] [Full Text] [Related]

  • 5. TGF-β1 29T/C polymorphism and breast cancer risk: a meta-analysis involving 25,996 subjects.
    Huang Y, Li B, Qian J, Xie J, Yu L.
    Breast Cancer Res Treat; 2010 Oct; 123(3):863-8. PubMed ID: 20845106
    [Abstract] [Full Text] [Related]

  • 6. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [Abstract] [Full Text] [Related]

  • 7. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
    Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.
    Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
    [Abstract] [Full Text] [Related]

  • 8. Association of the angiotensin II type I receptor gene +1166 A>C polymorphism with hypertension risk: evidence from a meta-analysis of 16474 subjects.
    Niu W, Qi Y.
    Hypertens Res; 2010 Nov; 33(11):1137-43. PubMed ID: 20703234
    [Abstract] [Full Text] [Related]

  • 9. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [Abstract] [Full Text] [Related]

  • 10. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
    Qiu LX, Yao L, Xue K, Zhang J, Mao C, Chen B, Zhan P, Yuan H, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
    [Abstract] [Full Text] [Related]

  • 11. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
    Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC.
    Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
    [Abstract] [Full Text] [Related]

  • 12. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
    Yao L, Yu X, Yu L.
    Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
    [Abstract] [Full Text] [Related]

  • 13. The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
    Colleran G, McInerney N, Rowan A, Barclay E, Jones AM, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E.
    Breast Cancer Res Treat; 2010 Jan; 119(2):437-42. PubMed ID: 19390964
    [Abstract] [Full Text] [Related]

  • 14. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.
    Yu KD, Di GH, Fan L, Chen AX, Yang C, Shao ZM.
    Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205
    [Abstract] [Full Text] [Related]

  • 15. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
    Qiu LX, Yao L, Mao C, Chen B, Zhan P, Yuan H, Xue K, Zhang J, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.